Masimo ROA 2007-2018 | MASI

Current and historical return on assets (ROA) values for Masimo (MASI) over the last 10 years.
Masimo Annual ROA - Return on Assets
2017 14.46
2016 36.64
2015 13.54
2014 13.16
2013 12.70
2012 16.53
2011 17.50
2010 23.66
2009 15.16
2008 10.88
2007 17.94
2006 114.30
2005 0.00
Masimo Quarterly ROA - Return on Assets
Q2 2018 4.35
Q1 2018 4.81
Q4 2017 -0.47
Q3 2017 4.33
Q2 2017 5.04
Q1 2017 5.87
Q4 2016 26.24
Q3 2016 4.34
Q2 2016 4.98
Q1 2016 4.44
Q4 2015 4.16
Q3 2015 3.10
Q2 2015 3.20
Q1 2015 3.45
Q4 2014 3.86
Q3 2014 3.03
Q2 2014 2.80
Q1 2014 4.90
Q4 2013 2.09
Q3 2013 3.62
Q2 2013 3.69
Q1 2013 4.23
Q4 2012 3.96
Q3 2012 3.31
Q2 2012 4.66
Q1 2012 4.15
Q4 2011 3.87
Q3 2011 3.96
Q2 2011 4.81
Q1 2011 5.54
Q4 2010 5.36
Q3 2010 5.11
Q2 2010 4.63
Q1 2010 8.98
Q4 2009 3.98
Q3 2009 3.97
Q2 2009 4.20
Q1 2009 4.35
Q4 2008 -0.18
Q3 2008 4.82
Q2 2008 4.23
Q1 2008 3.87
Q4 2007 5.12
Q3 2007 4.70
Q2 2007 6.06
Q1 2007 0.00
Q3 2006 0.00
Q2 2006 0.00
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $5.813B $0.798B
Masimo Corporation is a global medical technology company that develops and manufactures innovative noninvasive patient monitoring technologies, medical devices, and a wide array of sensors. They believe that Masimo SET helps clinicians monitor in excess of approximately million patients in healthcare settings around the world, and is the pulse oximeter technology used by the top hospitals. Masimo as a private `garage start-up` company because they convinced that the use of adaptive signal processing in the measurement of physiological parameters could solve the problems of low perfusion and motion, which had long plagued in-vivo monitoring and especially pulse oximetry, the measurement of the oxygen saturation of arterial blood. His solution, Masimo SET Measure-through Motion and Low Perfusion pulse oximetry, was shown in a study comparing three pulse oximetry technologies to demonstrate the highest sensitivity and specificity in identifying desaturation events during conditions of motion and low perfusion.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $92.240B 22.13
Intuitive Surgical (ISRG) United States $59.464B 56.76
Fresenius Medical Care (FMS) Germany $29.150B 20.59
Edwards Lifesciences (EW) United States $28.868B 32.52
IDEXX Laboratories (IDXX) United States $20.918B 63.57
ABIOMED (ABMD) United States $16.317B 133.67
DexCom (DXCM) United States $10.947B 0.00
Teleflex (TFX) United States $10.762B 25.60
Hologic (HOLX) United States $10.452B 17.78
Varian Medical Systems (VAR) United States $10.008B 25.19
STERIS (STE) United Kingdom $9.554B 26.28
LivaNova (LIVN) United Kingdom $5.902B 35.21
Integra LifeSciences Holdings (IART) United States $5.279B 27.32
Globus Medical (GMED) United States $5.081B 33.80
Inogen (INGN) United States $4.882B 129.19
Penumbra (PEN) United States $4.258B 387.03
Cantel Medical (CMD) United States $3.939B 41.06
Halyard Health (AVNS) United States $2.974B 24.47
Opko Health (OPK) United States $2.944B 0.00
Wright Medical Group (WMGI) Netherlands $2.910B 0.00
Integer Holdings (ITGR) United States $2.201B 19.93
Nevro (NVRO) United States $1.868B 0.00
Tandem Diabetes Care (TNDM) United States $1.757B 0.00
AxoGen (AXGN) United States $1.408B 0.00
Glaukos (GKOS) United States $1.379B 790.00
Natus Medical (BABY) United States $1.224B 25.96
Luminex (LMNX) United States $1.201B 35.43
Accelerate Diagnostics (AXDX) United States $1.180B 0.00
CryoLife (CRY) United States $1.179B 103.39
Mazor Robotics (MZOR) Israel $1.131B 0.00
Tactile Systems Technology (TCMD) United States $1.056B 180.00
TransEnterix (TRXC) United States $0.917B 0.00
K2Ms (KTWO) United States $0.875B 0.00
Intersect ENT (XENT) United States $0.813B 0.00
AngioDynamics (ANGO) United States $0.794B 29.49
Mesa Laboratories (MLAB) United States $0.790B 48.90
ViewRay (VRAY) United States $0.727B 0.00
Sientra (SIEN) United States $0.597B 0.00
Neuronetics (STIM) United States $0.574B 0.00
Pacific Biosciences Of California (PACB) United States $0.565B 0.00
Veracyte (VCYT) United States $0.418B 0.00
GenMark Diagnostics (GNMK) United States $0.401B 0.00
Quotient (QTNT) Switzerland $0.390B 0.00
OrthoPediatrics (KIDS) United States $0.371B 0.00
Oxford Immunotec Global (OXFD) United Kingdom $0.366B 0.00
IRadimed (IRMD) United States $0.299B 107.69
Accuray (ARAY) United States $0.298B 0.00
RTI Surgical (RTIX) United States $0.288B 56.88
T2 Biosystems (TTOO) United States $0.287B 0.00
Fluidigm (FLDM) United States $0.273B 0.00
Nuvectra (NVTR) United States $0.270B 0.00
CRH Medical (CRHM) Canada $0.258B 32.27
Pulse Biosciences (PLSE) United States $0.246B 0.00
Helius Medical Technologies (HSDT) United States $0.222B 0.00
SeaSpine Holdings (SPNE) United States $0.201B 0.00
Ekso Bionics Holdings (EKSO) United States $0.186B 0.00
Corindus Vascular Robotics (CVRS) United States $0.166B 0.00
Apollo Endosurgery (APEN) United States $0.165B 0.00
Alphatec Holdings (ATEC) United States $0.140B 0.00
Second Sight Medical Products (EYES) United States $0.101B 0.00
Viveve Medical (VIVE) United States $0.099B 0.00
Sensus Healthcare (SRTS) United States $0.096B 0.00
HTG Molecular Diagnostics (HTGM) United States $0.094B 0.00
EDAP TMS (EDAP) France $0.091B 0.00
Invuity (IVTY) United States $0.082B 0.00
Xtant Medical Holdings (XTNT) United States $0.081B 0.00
Neovasc (NVCN) Canada $0.066B 0.00
ConforMIS (CFMS) United States $0.057B 0.00
Restoration Robotics (HAIR) United States $0.050B 0.00
Electromed (ELMD) United States $0.043B 23.64
Vermillion (VRML) United States $0.039B 0.00
PAVmed (PAVM) United States $0.037B 0.00
Presbia (LENS) Ireland $0.036B 0.00
ReWalk Robotics (RWLK) Israel $0.033B 0.00
OBALON THERPTCS (OBLN) United States $0.032B 0.00
Lianluo Smart (LLIT) China $0.028B 0.00
Titan Medical (TMDI) Canada $0.025B 0.00
Microbot Medical (MBOT) United States $0.025B 0.00
DarioHealth (DRIO) Israel $0.024B 0.00
Dynatronics (DYNT) United States $0.023B 0.00
Navidea Biopharmaceuticals (NAVB) United States $0.022B 0.00
Nanovibronix (NAOV) United States $0.018B 0.00
American Shared Hospital Services (AMS) United States $0.017B 13.64
Bioanalytical Systems (BASI) United States $0.015B 0.00
Allied Healthcare Products (AHPI) United States $0.010B 0.00
Micron Solutions (MICR) United States $0.010B 0.00
ENDRA Life Sciences (NDRA) United States $0.009B 0.00
Sunshine Heart Inc (CHFS) United States $0.007B 0.00
Avinger (AVGR) United States $0.006B 0.00
Atossa Genetics (ATOS) United States $0.006B 0.00
Cesca Therapeutics (KOOL) United States $0.006B 0.00
InspireMD (NSPR) Israel $0.005B 0.00
Amedica (AMDA) United States $0.002B 0.00
EnteroMedics (RSLS) United States $0.001B 0.00
Check-Cap (CHEK) Israel $0.000B 0.00